The short version of NAMPT fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-05. Anything still debated is marked as such rather than presented as settled.
In the NAD+ salvage pathway, the enzyme NAMPT converts nicotinamide and a phosphate-donor molecule into NMN. A second enzyme, NMNAT, then converts NMN into NAD+. Nicotinamide riboside can also enter this route after being converted to NMN by nicotinamide riboside kinases. Because NMN sits at a junction between precursor uptake and NAD+ formation, its cellular concentration is tightly linked to enzyme activity and tissue type. NAD+ participates in redox reactions, signaling, and DNA repair, and its levels decline with age in some animal models, though human evidence remains more limited and context-dependent.
Research interest in NMN increased after animal studies reported that oral or injected NMN can raise NAD+ levels in some tissues. How NMN is absorbed and distributed in humans is not fully established. Some evidence suggests extracellular NMN may be dephosphorylated to nicotinamide riboside before cellular uptake, while other studies propose specific transport routes. Direct human data on these mechanisms remain limited. Regulatory status also varies: in some countries NMN is treated as a dietary supplement, while elsewhere it is restricted or requires approval, and these differences affect labeling, sale, and research.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Common name; beta form often denoted beta-NMN |
| Chemical formula | C11H15N2O8P | As free acid; salt forms differ |
| Molar mass | 334.22 g/mol | Calculated for the free acid |
| CAS Registry Number | 1094-61-7 | For beta-nicotinamide mononucleotide |
| Biochemical role | NAD+ intermediate | Participates in the salvage biosynthesis pathway |
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Solid NMN is a polar, water-soluble nucleotide that can absorb moisture from air. Its phosphate ester is susceptible to hydrolysis, and degradation is faster in aqueous solution, under strongly acidic or alkaline conditions, and at elevated temperatures. For laboratory and commercial handling, the solid is typically kept desiccated, protected from light, and stored frozen. Repeated freeze-thaw cycles can introduce moisture and accelerate breakdown. Stability data for specific formulations should be generated rather than assumed from the parent compound.
Identity and purity of NMN are commonly assessed by liquid chromatography with ultraviolet detection or mass spectrometry. High-performance liquid chromatography can separate related impurities such as nicotinamide, nicotinamide riboside, and NAD+ depending on the method. Mass spectrometry provides molecular mass confirmation, while nuclear magnetic resonance spectroscopy helps establish structure and anomeric form. Quantitative assays often use calibration curves and, in biological samples, stable isotope-labeled internal standards. Method validation addresses specificity, linearity, accuracy, precision, and limits of detection.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
== Fission products decay and burnup == One of the common fission products is 135Te, which undergoes beta decay with half-life of 19 seconds to 135I. 135I itself is a weak neutron absorber. It builds up in the reactor at a rate proportional to the rate of fission, which is proportional to the reactor thermal power. 135I undergoes beta decay with half-life of 6.57 hours to 135Xe. The yield of 135Xe for uranium fission is 6.3%; about 95% of 135Xe originates from decay of 135I. 135Xe is the most powerful known neutron absorber, with a cross section for thermal neutrons of 2.6×106 barns, so it acts as a "poison" that can slow or stop the chain reaction after a period of operation. This was discovered in the earliest nuclear reactors built by the Manhattan Project for plutonium production. As a result, the designers made provisions in the design to increase the reactor's reactivity (the number of neutrons per fission that go on to fission other atoms of nuclear fuel). 135Xe reactor poisoning played a major role in the Chernobyl disaster. By neutron capture, 135Xe is transformed ("burned") to 136Xe, which is effectively stable and does not significantly absorb neutrons. The burn rate is proportional to the neutron flux, which is proportional to the reactor power; a reactor running at twice the power has twice the xenon burn rate. The production rate is also proportional to reactor power, but due to the half-life time of 135I, this rate depends on the average power over the past several hours.
Gueriguian, cited Rezulin's potential to harm the liver and the heart, and he questioned its viability in lowering blood sugar for patients with adult-onset diabetes, recommending against the drug's approval. After complaints from the drugmaker, Gueriguian was removed on November 4, 1996, and his review was purged by the FDA. Gueriguian and the company had a single meeting at which Gueriguian used "intemperate" language; the company said its objections were based on inappropriate remarks made by Gueriguian. Parke-Davis said at the advisory committee that the risk of liver toxicity was comparable to placebo and that additional data of other studies confirmed this. According to Peter Gøtzsche, when the company provided these additional data one week after approval, they showed a substantially greater risk for liver toxicity. The FDA approved the drug on January 29, 1997, and it appeared in pharmacies in late March. At the time, Dr. Solomon Sobel, a director at the FDA overseeing diabetes drugs, said in a New York Times interview that adverse effects of troglitazone appeared to be rare and relatively mild. Glaxo Wellcome received approval from the British Medicines Control Agency (MCA) to market troglitazone, as Romozin, in July 1997. After reports of sudden liver failure in patients receiving the drug, Parke-Davis and the FDA added warnings to the drug label requiring monthly monitoring of liver enzyme levels. Glaxo Wellcome removed troglitazone from the market in Britain on December 1, 1997.
On 10 September 2008, Matthew Bryza said before the Commission on Security and Cooperation in Europe, "But there's much more to the story than that. The conflict certainly did not begin on August 7th. [...] Already we saw that the Russian peacekeepers were playing a role in providing a shield, we believe, to the South Ossetians who were shooting at the Georgian positions." After the war, Irakli Okruashvili, who served as Minister of Defence of Georgia, claimed that he and President Saakashvili had prepared plans to retake South Ossetia and Abkhazia in 2005. The alleged original plans intended a two-pronged offensive into South Ossetia. Saakashvili believed that a Russian response would be checked by the United States through diplomacy, so he did not order the taking of the Roki Tunnel. Georgian forces raced to contain the Russian forces, but were "outmaneuvered by the Russians." Okruashvili said that Russian response would be "inevitable" as after 2006, Russians "repositioned and improved their military infrastructure in the North Caucasus, Abkhazia, and South Ossetia." The Georgian Army could have defended a few major towns from the Russians, but President Saakashvili "let the Russians in to avoid criticism and appear more of a victim". In September 2008, Matthew Bryza said there was no disagreement between the intercepted phone conversations (which were presented as evidence of Russian invasion on 7 August) and August 7 statements of Georgian officials made during the phone calls between Bryza and Georgians.
Sources: en.wikipedia.org
=== Political activism === In 2005, Freeman criticized the celebration of Black History Month, saying: "I don't want a black history month. Black history is American history." He opined that the only way to end racism is to stop talking about it, and he noted that there is no "white history month". In an interview with 60 Minutes's Mike Wallace, Freeman said: "I am going to stop calling you a white man and I'm going to ask you to stop calling me a black man." Freeman supported the defeated proposal to change the Mississippi state flag, which incorporated the Confederate battle flag at the time. In an interview on CNN's Piers Morgan Tonight, Freeman drew controversy when he accused the Tea Party movement of racism. Regarding the 2015 Baltimore protests, Freeman said he was "absolutely" supportive of the protesters. "That unrest [in Baltimore] has nothing to do with terrorism at all, except the terrorism we suffer from the police ... Because of the technology—everybody has a smartphone—now in reaction to the death of Freddie Gray we can see what the police are doing. We can show the world, 'Look, this is what happened in that situation.' So why are so many people dying in police custody? And why are they all Black? And why are all the police killing them white? What is that? The police have always said, 'I feared for my safety.' Well, now we know. OK. You feared for your safety while a guy was running away from you, right?" During the 2008 presidential election, Freeman endorsed Barack Obama's presidential bid, although he said he would not join Obama's campaign.
== Procedure == When performing RK, incisions are made with a diamond knife. The incisions relax the steep central cornea in patients with myopia in order to achieve a decreased need for correction. The original technique – consisting of incisions from periphery to center – was called the "Russian technique", while the later advances of performing controlled incision from center to periphery was called the "American technique". RK may be performed with different types, numbers, and patterns of incisions. Typically, between 4 and 24 radial incisions are made in a number of patterns and orientations based on refractive errors, surgeon style and surgeon training. RK with 8 incisions is most common. Incisions that penetrate only the superficial corneal stroma are less effective than those reaching deep into the cornea, and consequently, incisions are made quite deep. One study cites incisions made to a depth equivalent to the thinnest of four corneal-thickness measurements made near the center of the cornea. Other sources cite surgeries leaving 20 to 50 micrometres of corneal tissue unincised (roughly equivalent to 90% of corneal depth, based on thickness norms).
Prioritize agricultural production of a diverse range of nutrient-rich foods; Protect nutrient-rich wild foods and species-rich ecosystems on land and in oceans; Support connectivity of smallholders and Small and Medium Sized Enterprises (SMEs) across food value chains; Redesign safety net/social protection programs towards improved nutritional outcome; Reduce food loss and food waste; Improve food quality and safety; Strengthen regulations for advertising and marketing; Improve transparency in food labeling; Encourage healthier eating through subsidies and promotions of healthy foods and taxes on unhealthy foods; Create consumer demand for healthy foods (nutrition education & civic engagement); Improve acceptability of healthy foods; Promote traditional foods and methods that impart nutritional benefits; Invest in metrics, research, and access to inform policy development.
Sources: en.wikipedia.org
Nicotinamide mononucleotide is a nucleotide intermediate in the biosynthesis of NAD+. It consists of nicotinamide attached to a ribose phosphate unit. NMN occurs naturally in cells and is present at low levels in some foods.
NMN is a direct precursor in the NAD+ salvage pathway. Enzymes called NMNAT convert NMN into NAD+, a coenzyme used in metabolism and cell signaling. Raising NMN may increase NAD+ in some experimental settings, but the effect depends on tissue and organism.
No. Nicotinamide riboside is a related compound that lacks the phosphate group present in NMN. Cells can convert nicotinamide riboside into NMN, and both compounds feed into NAD+ production through overlapping routes.
Liquid chromatography with tandem mass spectrometry is common because it can quantify low levels of NMN in complex samples. High-performance liquid chromatography with ultraviolet detection is used for simpler purity checks. Nuclear magnetic resonance can confirm identity and detect some impurities.